MDMA, New Hampshire Contingent Join Opposition to Patent Reform Act | GenomeWeb
NEW YORK (GenomeWeb News) — The Medical Devices Manufacturers Association and a private-public New Hampshire-based contingent last week joined the growing list of organizations opposing the Patent Reform Act of 2007, currently under bi-cameral review in the US Congress.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: carbapenem resistance in Enterobacteriaceae, selection against educational attainment-linked variants, and more.

Technology Review points out that a new US presidential science advisor hasn't been selected.

Researchers find that blood tests might be able to help determine severity of a concussion, Wired reports.

President-elect Donald Trump considers other candidates for director of the National Institutes of Health, Nature News reports.